<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Niche-Buster Medicine Information Solutions</title><link>/community-hubs/deltav-community-connect/b/ops-weblog/posts/niche-buster-medicine-information-solutions-14794596</link><description>Author: Michalle Adkins 
 
 We are seeing a trend in the life sciences industry moving away from blockbusters to niche busters, population based medicines and even to the extreme of personalized medicines. The Emerson Life Sciences consulting team recently</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>